Free Trial

Option Care Health (NASDAQ:OPCH) Sets New 12-Month Low - Should You Sell?

Option Care Health logo with Medical background

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $21.54 and last traded at $21.54, with a volume of 3973 shares traded. The stock had previously closed at $21.74.

Analysts Set New Price Targets

Several research analysts have commented on the company. Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. Bank of America downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and decreased their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Jefferies Financial Group downgraded Option Care Health from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. JMP Securities increased their target price on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a research note on Monday, September 30th. Finally, The Goldman Sachs Group lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $30.83.

Check Out Our Latest Stock Report on Option Care Health

Option Care Health Price Performance

The stock has a 50 day moving average of $28.41 and a two-hundred day moving average of $29.31. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market cap of $3.71 billion, a PE ratio of 18.27, a PEG ratio of 2.27 and a beta of 1.32.

Insider Transactions at Option Care Health

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the business's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company's stock, valued at approximately $663,429.51. The trade was a 69.02 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares of the company's stock, valued at approximately $7,654,461.15. The trade was a 8.58 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by insiders.

Institutional Trading of Option Care Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Wellington Management Group LLP lifted its stake in shares of Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock worth $310,650,000 after buying an additional 1,328,326 shares during the last quarter. FMR LLC raised its holdings in Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP lifted its position in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock worth $203,204,000 after acquiring an additional 599,589 shares during the last quarter. State Street Corp boosted its holdings in Option Care Health by 1.4% during the third quarter. State Street Corp now owns 6,257,172 shares of the company's stock valued at $195,849,000 after acquiring an additional 83,395 shares during the period. Finally, Thrivent Financial for Lutherans grew its position in shares of Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company's stock valued at $183,541,000 after purchasing an additional 404,811 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

About Option Care Health

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Read More

Should you invest $1,000 in Option Care Health right now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines